Last Close
Jun 22  •  04:00PM ET
140.73
Dollar change
-5.27
Percentage change
-3.61
%
Jun 22, 7:10 AMICON plc selects Microsoft as preferred technology partner to scale its Orbis agentic AI clinical trial platform
Index
-
P/E
50.21
EPS (ttm)
2.80
Insider Own
0.93%
Shs Outstand
76.57M
Perf Week
-3.73%
Market Cap
10.78B
Forward P/E
11.99
EPS next Y
11.73
Insider Trans
0.00%
Shs Float
75.84M
Perf Month
22.28%
Enterprise Value
13.68B
PEG
6.63
EPS next Q
2.44
Inst Own
105.02%
Perf Quarter
41.15%
Income
229.34M
P/S
1.31
EPS this Y
-15.80%
Inst Trans
3.97%
Perf Half Y
-21.53%
Sales
8.25B
P/B
1.17
EPS next Y
11.23%
ROA
1.38%
Perf YTD
-22.77%
Book/sh
120.07
P/C
16.65
EPS next 5Y
1.81%
ROE
2.45%
52W High
211.00 -33.30%
Perf Year
-3.93%
Cash/sh
8.45
P/FCF
12.12
EPS past 3/5Y
-22.33% -14.31%
ROIC
1.88%
52W Low
66.57 111.40%
Perf 3Y
-38.09%
Dividend Est.
-
EV/EBITDA
9.56
Sales past 3/5Y
2.15% 24.15%
Gross Margin
21.72%
Volatility
3.90% 5.45%
Perf 5Y
-33.72%
Dividend TTM
-
EV/Sales
1.66
EPS Y/Y TTM
-70.42%
Oper. Margin
12.27%
ATR (14)
6.86
Perf 10Y
110.45%
Dividend Ex-Date
-
Quick Ratio
1.10
Sales Y/Y TTM
-0.37%
Profit Margin
2.78%
RSI (14)
54.29
Dividend Gr. 3/5Y
- -
Current Ratio
1.10
EPS Q/Q
-38.96%
SMA20
0.18%
Beta
1.25
Payout
0.00%
Debt/Eq
0.39
Sales Q/Q
3.50%
SMA50
12.43%
Rel Volume
0.81
Prev Close
146.00
Employees
40100
LT Debt/Eq
0.33
SMA200
-5.88%
Avg Volume
1.14M
Price
140.73
IPO
May 15, 1998
Option/Short
Yes / Yes
Trades
Volume
918,708
Change
-3.61%
Date Action Analyst Rating Change Price Target Change
May-18-26Resumed RBC Capital Mkts Sector Perform $123
Mar-26-26Upgrade BMO Capital Markets Market Perform → Outperform $130
Feb-23-26Upgrade Jefferies Hold → Buy $135
Feb-18-26Upgrade TD Cowen Hold → Buy $120
Feb-17-26Downgrade Rothschild & Co Redburn Buy → Neutral $100
Feb-12-26Downgrade Leerink Partners Outperform → Market Perform $105
Feb-12-26Downgrade BofA Securities Neutral → Underperform $75
Jan-08-26Downgrade Truist Buy → Hold $222
Dec-15-25Downgrade BofA Securities Buy → Neutral $195
Nov-13-25Initiated BMO Capital Markets Market Perform $175
Jun-22-26 07:00AM
Jun-17-26 04:15PM
May-29-26 08:30AM
May-28-26 07:02PM
May-18-26 09:55AM
08:00AM Loading…
May-13-26 08:00AM
Mar-26-26 09:45AM
Mar-24-26 08:00AM
Mar-11-26 06:00AM
Mar-10-26 09:11AM
Mar-09-26 12:17AM
Mar-05-26 09:56AM
Mar-02-26 12:55AM
Mar-01-26 04:23AM
Feb-26-26 06:45PM
02:46PM Loading…
Feb-24-26 02:46PM
Feb-23-26 09:08PM
Feb-18-26 10:10AM
Feb-17-26 09:43AM
Feb-15-26 08:32AM
Feb-14-26 08:17AM
Feb-13-26 11:25PM
Feb-12-26 04:16PM
02:19PM
11:10AM
10:07AM
09:44AM
07:38AM
Feb-11-26 10:00AM
Feb-05-26 07:23PM
07:15AM Loading…
Jan-27-26 07:15AM
Jan-22-26 12:06AM
Jan-05-26 07:27AM
Dec-17-25 08:53AM
Dec-10-25 10:31AM
Dec-09-25 07:46AM
07:15AM
Dec-02-25 07:15AM
Nov-27-25 11:30AM
Nov-26-25 06:27PM
Nov-25-25 07:46AM
Nov-21-25 11:30AM
Nov-13-25 09:11AM
Nov-12-25 06:45AM
Nov-06-25 07:28PM
Oct-24-25 06:41PM
Oct-23-25 11:15AM
Oct-22-25 05:45PM
04:25PM
Oct-20-25 10:00AM
Oct-15-25 10:00AM
Oct-01-25 06:48PM
Sep-26-25 08:52AM
Sep-14-25 01:17AM
Sep-09-25 12:11PM
Sep-04-25 08:00AM
Sep-02-25 06:00AM
Sep-01-25 12:20PM
Aug-18-25 06:45PM
Aug-12-25 11:41PM
08:54AM
Aug-11-25 07:50AM
Aug-06-25 06:42PM
Jul-25-25 09:45PM
Jul-24-25 06:37PM
Jul-23-25 05:50PM
04:20PM
04:15PM
Jul-17-25 10:00AM
Jul-16-25 10:00AM
07:15AM
Jul-15-25 09:32AM
Jul-07-25 07:15AM
07:06AM
Jul-03-25 10:13AM
Jun-27-25 09:15AM
Jun-23-25 06:30AM
Jun-02-25 10:23AM
04:12AM
May-30-25 11:31AM
May-27-25 08:30AM
May-19-25 04:15PM
May-14-25 07:52AM
May-09-25 03:13AM
May-07-25 12:55PM
07:27AM
May-02-25 09:00PM
03:01AM
02:42AM
May-01-25 06:43PM
09:16AM
Apr-30-25 06:15PM
05:23PM
04:15PM
Apr-29-25 09:12AM
Apr-27-25 04:19PM
Apr-24-25 10:01AM
Apr-23-25 10:01AM
Apr-22-25 07:20AM
Apr-10-25 09:26AM
ICON plc engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The firm specializes in the development, management, and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S., and Rest of World. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
CEO & DirectorMr. Barry Balfe
Founder & Independent Non-Executive DirectorDr. John Climax Ph.D.
Chief Financial OfficerMr. Nigel Clerkin A.C.A.
Chief Commercial OfficerMr. Steve Empoliti
Chief Accounting OfficerLyons Emer
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARRY EDWARD BALFEOfficerMar 09 '26Proposed Sale105.132,862300,875Mar 09 05:14 PM
BARRY EDWARD BALFEOfficerMar 04 '26Proposed Sale109.2556661,837Mar 04 04:07 PM
NIGEL CLERKINOfficerNov 03 '25Proposed Sale169.241,473249,289Nov 03 04:23 PM
STEPHEN CUTLEROfficerOct 02 '25Proposed Sale190.1918,9013,594,781Oct 02 04:03 PM
BARRY EDWARD BALFEOfficerAug 08 '25Proposed Sale157.4638159,993Aug 08 04:33 PM
THOMAS NOEL O'LEARYOfficerAug 08 '25Proposed Sale157.461,136178,877Aug 08 04:27 PM